Page 125 - fbkCardioDiabetes_2017
P. 125

Cardio Diabetes Medicine 2017                                    101





                 be  measured  during  follow-up  to detect orthostatic   tion. Measurement of 24-hour urinary metanephrines
                 complications with treatment.                      or plasma metanephrines is an effective screen when
                                                                    pheochomocytoma is suspected.
                 Physical Examination
                 A  fundoscopic examination should document  the    Noninvasive Imaging
                 presence  and severity  of  retinopathy. The  presence   Imaging for renal artery stenosis should be reserved
                 of carotid, abdominal, or femoral bruits increases the   for patients in whom  there is an  increased level  of
                 possibility  that renal  artery  stenosis  exists.  Dimin-  suspicion. This would include young patients, particu-
                 ished femoral pulses and/or a discrepancy between   larly women, whose presentation suggests the pres-
                 arm and thigh blood pressures suggest aortic coarc-  ence of fibromuscular dysplasia  and  older  patients
                 tation or significant aortoiliac disease. Cushing’s dis-  at increased  risk  of atherosclerotic disease.  Due to
                 ease is suggested by abdominal striae, particularly if   poor  specificity, abdominal CT  imaging  is  not rec-
                 pigmented; moon facies; or prominent interscapular   ommended to screen  for  adrenal adenomas in the
                 fat deposition.                                    absence of biochemical  confirmation  of hormonally
                                                                    active tumors (hyperaldosteronism,pheochromocyto-
                 Ambulatory Blood Pressure Monitoring               ma , Cushing’s syndrome).
                 Documentation  of a significant  white-coat  effect   Treatment Recommendations
                 requires  reliable  assessment of out-of-office blood
                 pressure  values. This  is  accomplished most objec-  Resistant hypertension is almost always multifactori-
                 tively with the use of 24-hour ambulatory blood pres-  al in etiology. Treatment is predicated on identification
                 sure monitoring.                                   and reversal of lifestyle factors contributing to treat-
                                                                    ment resistance; accurate diagnosis and appropriate
                 A significant  white-coat  effect  should be suspected   treatment of secondary causes of hypertension; and
                 in patients with resistant hypertension in whom clinic   use of effective multi-drug regimens.Lifestyle chang-
                 blood pressure measurements are consistently high-  es, including weight loss; regular exercise; ingestion
                 er than out-of-office measurements; in patients who   of a high-fiber, low-fat, low-salt diet; and moderation
                 repetitively show signs of overtreatment, particularly   of alcohol intake.
                 orthostatic symptoms; and in patients with chronical-  Potentially  interfering  substances should be  with-
                 ly high office blood pressure values but an absence   drawn  or down-titrated  as clinically  allowable. Ob-
                 of target organ damage (LVH, retinopathy, CKD).  In   structive sleep apnea should be treated if present.
                 such cases, 24-hour ABPM is recommended. A mean
                 ambulatory  daytime blood pressure  of >135/85 mm
                 Hg is considered elevated. If a significant white-coat   Maximize Adherence
                 effect is  confirmed, out-of-office measurements   Prescribed regimens should be simplified as much as
                 should be relied on to adjust treatment.           possible, including the use of a long-acting combina-
                                                                    tion of products to reduce the number of prescribed
                 Biochemical Evaluation                             pills  and to allow for  once-daily dosing.  Adherence
                                                                    is  also  enhanced  by  more  frequent  clinic visits  and
                 Biochemical evaluation of the treatment-resistant hy-  by having patients record home blood pressure mea-
                 pertensive should include a routine metabolic profile   surements.  Involving  the patient by  having him or
                 (sodium,  potassium, chloride, bicarbonate,  glucose,   her maintain a diary of home blood pressure values
                 blood  urea  nitrogen,  and creatinine); urinalysis;  and   should improve  follow-up  and enhance  medication
                 a paired,  morning plasma  aldosterone  and plasma   adherence, while involvement of family members will
                 renin or plasma renin activity  to screen for primary   likely  enhance persistence  with recommended life-
                 aldosteronism. Even in the setting of ongoing antihy-  style changes.
                 pertensive  treatment  (excluding potassium-sparing
                 diuretics, particularly  aldosterone  antagonists),  the
                 aldosterone/renin ratio is an effective screening test   Nonpharmacological Recommendations
                 for  primary  aldosteronism,  having a high negative   Weight Loss:  Weight loss, has a clear benefit in terms
                 predictive value.                                  of reducing blood pressure  and  often allows for  re-
                                                                    duction  in the  number  of prescribed  medications.
                 A 24-hour  urine collected  during ingestion of the   While difficult to achieve and even more  difficult to
                 patient’s normal diet can be helpful in estimating di-  maintain,  weight loss  should be encouraged in any
                 etary sodium and potassium intake, calculating cre-  patient with resistant hypertension  who is  either
                 atinine clearance, and measuring aldosterone excre-
                                                                    overweight or obese.

                                                    Cardio Diabetes Medicine
   120   121   122   123   124   125   126   127   128   129   130